In this study, we further demonstrated the result that MT genes (including MT1A, MT1B, and MT1M) were robustly downregulated in NASH compared with NAFL through integrated differential expression analysis with a larger sample size, suggesting a specific role of MT in the later stage of NAFLD. This evidence concerns the gene MT1A and metabolic dysfunction-associated steatotic liver disease.